Maynard Um
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Cabaletta Bio Inc. (CABA)
-
-
-
-
-
-
-
FDA removing REMS from several CAR-T cell therapies positive for these 3 stocks - William Blair
-
-
-
-
-
-
-
Cabaletta Bio Inc. (CABA) PT Lowered to $13 at Stifel
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Cabaletta Bio Inc. (CABA)
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

